Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy

Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy

Abstract Background Thrombocytopenia can rapidly improve in chronic hepatitis C (CHC) patients receiving direct-acting antiviral agents (DAA). The role of baseline (BL) thrombopoietin (TPO) in this phenomenon is unclear. Methods From June 2016 to February 2019, a total of 104 CHC patients receiving...

Full description

Bibliographic Details
Main Authors: Yen-Chun Chen, Ping-Hung Ko, Chi-Che Lee, Chih-Wei Tseng, Kuo-Chih Tseng
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Gastroenterology
Subjects:
Chronic hepatitis C
Direct-acting antiviral agents
Platelet
Thrombocytopenia
Thrombopoietin
Online Access:https://doi.org/10.1186/s12876-021-01606-x

Internet

https://doi.org/10.1186/s12876-021-01606-x

Similar Items